Brilliant Violet 421a,,cents anti-mouse CD71 [RI7217]

BioLegend Inc. has been awarded contract A207_PO-0489066 by the University of Virginia, a state contracting organization in Virginia, effective October 7, 2026. The cumulative contract value is $153. While specific details regarding the nature of products or services to be delivered under this award are not provided in the available documentation, BioLegend Inc.'s established business focus suggests the contract likely involves life sciences or research reagent supplies, though the exact scope of work cannot be definitively determined from the information provided.

Additional critical contract parameters—including the period of performance, place of performance, and detailed statement of work—are not contained within the source materials. To obtain comprehensive contract specifications, performance milestones, and delivery schedules, direct reference to the full contract documentation or the University of Virginia's procurement records would be necessary. The notably low cumulative value of $153 suggests this may represent a purchase order for limited quantities of specialized materials or services.